About | Free Trial

Last Update

2016-01-18T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Richard Pines?

Mr. Richard Pines T.

Partner

Athyrium Capital Management , LLC

Direct Phone: (646) ***-****       

Email: r***@***.com

Athyrium Capital Management , LLC

530 Fifth Avenue, Floor 25

New York, New York 10036

United States

Company Description

Athyrium Capital Management ("Athyrium") is a specialized asset management company formed in 2008 by Jeffrey A. Ferrell to focus on investment opportunities in the global healthcare sector. The Athyrium team has substantial investment experience in the ... more

Find other employees at this company (11)

Background Information

Affiliations

Board Member
Tria Beauty Inc

Education

B.S.
Accounting and Finance
Indiana University

Web References (12 Total References)


Our Board | Tria Beauty

www.triabeauty.com [cached]

Richard Pines

Partner, Athyrium Capital Management, LP
Richard Pines helped form Athyrium in 2008 and currently serves as a Partner. Mr. Pines' expertise lies in sourcing and identifying attractive investment opportunities through his deep network of contacts within the healthcare industry. He has been involved in every stage of the investment process including negotiating, structuring, executing and monitoring new investments. During his time at Athyrium, he led the following investments: BioFire Diagnostics, Verenium, Tria Beauty, Universal Biosensors, Retrophin, Synarc-Biocore, Apollo Endosurgery, Cipher Pharmaceuticals and HLS Therapeutics.
From 2005 to 2008, Mr. Pines worked at Barclays Capital and as part of the Lehman Brothers Global Trading Strategies life sciences team. While at Lehman Brothers, he had substantial involvement in the equity and structured investments life sciences portfolio. Representative structured investments include companies such as Jazz Pharmaceuticals, ISTA Pharmaceuticals, Nektar Therapeutics and Orthovita. Representative equity investments include companies such as Sequenom, Genentech, Incyte Corporation, Acorda Therapeutics, I-trax and Penwest Pharmaceuticals.
Prior to Lehman, he was an Analyst in Credit Suisse's Investment Banking Division focused on healthcare clients. Mr. Pines worked in a traditional healthcare coverage role before moving to a product group called the Buyside Insights Group, which provided strategic insights to the firm's clients utilizing a value-based framework.
Mr. Pines graduated with a B.S. in both Accounting and Finance from Indiana University in 2001....read more


Richard Pines, a Partner at ...

apolloendo.com [cached]

Richard Pines, a Partner at Athyrium, said "Athyrium is excited to partner with Apollo during this transformative time in the company's life.


Richard Pines of Athyrium ...

www.universalbiosensors.com [cached]

Richard Pines of Athyrium talks about the recent funding deal with UBI

...
Richard Pines of Athyrium talks about the recent funding deal with UBI


Richard Pines of Athyrium ...

www.universalbiosensors.com [cached]

Richard Pines of Athyrium talks about the recent funding deal with UBI

...
Richard Pines of Athyrium talks about the recent funding deal with UBI


Richard Pines of Athyrium ...

www.universalbiosensors.com.au [cached]

Richard Pines of Athyrium talks about the recent funding deal with UBI

...
Richard Pines of Athyrium talks about the recent funding deal with UBI

Similar Profiles

Other People with this Name

Other people with the name Pines

Zak Pines
Bedrock Data Inc

Wayne Pines
APCO Worldwide Inc

Michael Pines
The Manchester Rescue Squad Inc

Marina Pines
Continuiti LLC

Aaron Pines
Alpine Property Inspection

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory